BGI
Cancer Research
Genomics of Cancer and a New Era of Cancer Prevention
BGI is giving scientists access to the cutting-edge next-generation sequencing (NGS) that they need in order to be able to understand more about the genetics of cancer, opening new avenues for understanding patient response to treatment and for developing new targeted therapies and genetic tests, all of which are essential for making personalised medicine a reality.
BGI’s wide range of sequencing solutions support multiple cancer research applications, including studies of
  • Germline and somatic variants
  • Gene fusions
  • Copy number variants
  • RNA expression changes
  • Epigenetic alterations
NGS based cancer sequencing provides more information in less time compared to traditional array-based approaches.
Sequencing Solutions:
Research Areas
Tell Us About Your Project
首页